This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified vaccines and biological substances
VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
245 |
4. Check minimum number of eventsNone |
245 |
5. Include endpointsNone |
245 |
6. Filter based on genotype QC (FinnGen only) |
224 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y[4-5]
Similar endpoints
↥List of similar endpoints to
Other and unspecified vaccines and biological substances
based on the number of shared cases.
Similar with more cases:
- Drugs, medicaments and biological substances causing adverse effects in therapeutic use
- Complications of medical and surgical care
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 224 | 168 | 56 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 47.89 | 45.78 | 54.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 245
- Matched controls
- 2450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y59
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
16384.0
307.7
243
8
T78.4
ICD-10 Finland
Allergy, unspecified
24.4
111.0
90
57
C01CA24
ATC
epinephrine; parenteral
15.0
88.0
96
101
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
51.3
77.9
46
11
XQ800
NOMESCO Finland
Prick test
11.3
59.9
74
90
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.5
34.3
68
137
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
342.4
30.5
30
*
H02AB06
ATC
prednisolone; systemic
4.2
26.0
163
786
A92
ICPC
Allergy/allergic reaction NOS
8.2
21.3
30
41
T78.3
ICD-10 Finland
Angioneurotic oedema
25.1
19.5
27
12
R03DC03
ATC
montelukast; oral
3.8
19.5
79
274
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.4
18.3
53
144
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
18.8
17.9
27
16
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
16.0
74
276
J45.9
ICD-10 Finland
Asthma, unspecified
3.4
15.9
74
277
R4110
NOMESCO Finland
Physiotherapy
3.1
15.4
92
399
X58
ICD-10 Finland
Exposure to other specified factors
3.4
14.8
64
228
L50.9
ICD-10 Finland
Urticaria, unspecified
5.7
14.8
29
56
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
14.8
120
613
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.2
14.4
74
292
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.8
14.1
27
51
R03AC02
ATC
salbutamol; inhalant
3.0
13.4
176
1134
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
53.0
13.0
15
*
R42
ICD-10 Finland
Dizziness and giddiness
3.1
13.0
67
264
R06AE07
ATC
cetirizine; oral
2.7
13.0
142
829
J46
ICD-10 Finland
Status asthmaticus
10.9
12.3
23
23
R03BB04
ATC
tiotropium bromide; inhalant
4.3
12.0
33
85
Z3231
NOMESCO Finland
Registered nurse
2.7
11.9
88
419
WX892
NOMESCO Finland
Monitored bed care
4.3
11.4
31
79
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
11.3
52
190
J01FF01
ATC
clindamycin; systemic
2.7
11.3
87
421
Z3226
NOMESCO Finland
Physiotherapist
3.0
11.3
61
245
R06AX13
ATC
loratadine; oral
3.0
11.2
60
240
R06AX27
ATC
desloratadine; oral
2.5
11.0
105
563
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.0
10.9
34
96
H02AB07
ATC
prednisone; oral
3.4
10.9
45
154
E000001, ,
ATC
2.8
10.8
70
309
Z2221
NOMESCO Finland
Medical doctor
2.5
10.5
94
486
R03BA08
ATC
ciclesonide; inhalant
3.6
10.5
38
119
T88.1
ICD-10 Finland
Other complications following immunization, not elsewhere classified
114.7
10.5
11
*
R02
ICPC
Shortness of breath/dyspnoea
3.3
10.4
45
158
R06.0
ICD-10 Finland
Dyspnoea
2.6
10.3
79
379
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.0
10.2
23
50
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
10.1
107
595
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
10.0
117
680
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
9.7
79
389
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
11.3
9.4
17
16
XF600
NOMESCO Finland
Bloodpressure measurement
4.2
9.4
26
67
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
9.4
63
282
L28
ICPC
Limited function/disability (L)
3.0
9.0
45
172
R03AK08
ATC
formoterol and beclometasone; inhalant
4.4
8.9
23
56
N17
ICPC
Vertigo/dizziness
3.2
8.9
39
138
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.5
8.9
22
52
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
8.8
61
276
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
6.9
8.7
21
33
Z2446
NOMESCO Finland
Social worker
3.6
8.7
30
91
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
17.1
8.6
13
8
L50.0
ICD-10 Finland
Allergic urticaria
7.2
8.6
20
30
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
8.3
34
115
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.3
76
391
X57
ICD-10 Finland
Unspecified privation
8.6
8.2
17
21
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
8.2
87
477
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.0
8.1
24
65
R03BA02
ATC
budesonide; inhalant
2.5
8.1
61
287
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
8.1
44
176
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
8.0
41
158
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
8.0
49
208
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
7.8
28
87
S01GX01
ATC
cromoglicic acid; ophthalmic
2.4
7.8
68
342
R01AD58
ATC
fluticasone, combinations; nasal
2.2
7.7
83
455
A02BA02
ATC
ranitidine; systemic
2.6
7.7
49
212
J45
ICD-10 Finland
Asthma
3.0
7.5
35
128
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.9
7.5
23
64
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
7.4
35
129
ZXE00
NOMESCO Finland
One hour or less
2.1
7.3
111
694
R03AC03
ATC
terbutaline; inhalant
2.6
7.1
45
194
Z50.1
ICD-10 Finland
Other physical therapy
4.2
7.0
19
48
A02BC05
ATC
esomeprazole; systemic
2.1
7.0
105
652
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
14.3
7.0
11
8
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
6.9
24
73
E0000UV, ,
ATC
2.0
6.9
115
742
N03AX16
ATC
[U] pregabalin
2.3
6.8
62
315
S21
ICPC
Skin texture symptom/complaint
2.6
6.8
45
198
Y34
ICD-10 Finland
Unspecified event, undetermined intent
41.2
6.8
8
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.8
6.8
16
25
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.9
6.7
34
130
D01AE15
ATC
terbinafine; topical
4.0
6.7
19
50
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
6.6
29
102
ZXA00
NOMESCO Finland
Right side
2.3
6.6
62
319
Z51.6
ICD-10 Finland
Desensitization to allergens
10.4
6.6
12
12
J01AA02
ATC
doxycycline; systemic
2.2
6.6
188
1462
R03BA05
ATC
fluticasone; inhalant
2.3
6.6
61
313
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.6
36
144
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
6.5
34
132
J01FA06
ATC
roxithromycin; oral
2.0
6.5
104
656
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
6.5
159
1164
C07AB07
ATC
bisoprolol; oral
2.0
6.5
101
631
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.5
94
573
R60.0
ICD-10 Finland
Localized oedema
2.9
6.5
32
121
N06AX26
ATC
vortioxetine; oral
3.0
6.4
29
104
J01MA14
ATC
moxifloxacin; systemic
3.0
6.4
29
104
N06AX16
ATC
venlafaxine; oral
2.4
6.4
48
224
D06
ICPC
Abdominal pain localized other
2.8
6.4
33
128
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.4
6.3
46
212
A97
ICPC
No disease
2.3
6.3
56
282
R06AX26
ATC
fexofenadine; oral
3.0
6.2
28
100
XF402
NOMESCO Finland
ECG with work load test
3.1
6.2
26
89
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.2
31
118
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.8
6.2
19
53
R50.9
ICD-10 Finland
Fever, unspecified
2.4
6.1
47
221
R01AD08
ATC
fluticasone; nasal
2.0
6.1
86
516
B01AB05
ATC
enoxaparin; parenteral
2.1
6.1
76
436
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
6.1
67
367
N02AX02
ATC
tramadol; systemic, rectal
2.0
6.0
103
662
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
74
304
3.05
13.37
4.2
2.8
195.61
193.13
ng/l
0.01
44
194
27
57
5.20
12.46
1.2
1.2
1.05
1.52
u/ml
0.21
17
30
174
1188
2.60
10.56
13.9
8.9
3.95
4.05
e9/l
0.29
153
1040
28
71
4.32
10.36
1.3
1.6
0.24
0.23
g/l
0.32
28
71
114
661
2.36
9.73
1.9
1.8
104.40
97.35
pmol/l
0.64
67
343
87
451
2.44
9.53
3.8
1.8
1.04
1.00
mg/l
0.04
65
346
121
730
2.30
9.30
7.6
4.6
36.31
36.36
g/l
0.03
112
697
20
46
4.65
8.31
1.2
1.1
2.63
2.93
u/ml
0.04
13
23
120
748
2.18
8.23
7.4
6.1
1.22
1.22
mmol/l
0.14
114
695
130
838
2.17
8.17
8.7
6.9
1.22
1.22
mmol/l
0.14
118
710
51
222
2.64
7.93
5.7
2.7
3.83
7.81
umol/l
1.76
45
191
73
382
2.30
7.59
1.5
1.4
19.83
22.44
nmol/l
0.70
64
331
21
55
4.08
7.42
4.7
2.7
—
—
—
0
0
7
0
+∞
7.32
1.0
0.0
—
—
—
0
0
36
136
2.93
7.29
3.7
4.6
1.47
2.07
mmol/l
0.64
29
102
84
475
2.17
7.18
2.9
2.1
2.84
3.01
mg/l
0.29
74
411
33
121
3.00
7.03
2.3
1.4
—
—
—
0
0
103
635
2.07
6.99
4.2
3.1
—
—
—
0
0
13
14
9.73
6.87
1.3
1.4
—
—
—
0
0
17
40
4.49
6.87
1.1
1.1
3.36
9.53
u/ml
0.76
12
16
56
273
2.36
6.79
2.4
1.8
—
—
—
0
0
44
192
2.57
6.76
2.3
1.7
—
—
—
0
0
12
12
10.44
6.61
1.7
1.3
—
—
—
0
0
59
302
2.26
6.36
3.5
2.5
0.32
0.93
e6/l
3.01
34
167
41
180
2.53
6.21
10.6
4.3
240.61
251.53
u/l
0.17
41
172
42
187
2.50
6.17
2.3
1.6
—
—
—
0
0
56
284
2.26
6.16
3.4
2.8
2.26
3.46
e6/l
0.58
32
151
40
175
2.54
6.10
2.5
2.1
30.48
29.59
u/l
0.08
31
138
16
40
4.21
6.00
16.4
5.4
369.40
847.33
iu/ml
—
5
6
16
40
4.21
6.00
1.2
1.1
15.30
4.89
u/ml
0.75
11
21
23
75
3.28
5.94
1.9
1.4
—
—
—
0
0
188
1490
2.13
5.87
5.1
3.8
12.14
9.91
mm/h
1.42
181
1373
118
805
1.90
5.68
2.8
2.3
76.11
75.04
nmol/l
0.16
108
731
144
1050
1.90
5.62
4.3
2.9
107.93
76.55
ug/l
0.45
138
979
109
735
1.87
5.35
13.1
9.9
1.15
1.15
inr
0.03
33
233
39
181
2.37
5.22
6.9
6.8
106.18
104.17
mmol/l
2.83
39
181
74
445
1.95
5.11
4.3
2.6
320.93
7656.93
umol/l
2.24
68
394
145
1080
1.84
5.08
6.7
4.3
6.57
6.40
mmol/l
0.46
132
981
9
9
10.32
5.07
1.4
3.4
1608.11
713.11
u/ml
—
9
9
82
512
1.90
5.06
4.3
2.8
0.22
0.31
e6/l
0.61
70
374
89
575
1.86
4.92
1.9
1.6
—
—
—
0
0
15
42
3.74
4.85
1.7
1.1
2.22
3.21
u/ml
—
9
14
17
52
3.44
4.84
1.2
1.2
—
47.28
—
0
6
32
141
2.46
4.79
6.3
6.1
1.30
1.22
mmol/l
0.22
32
136
167
1324
1.82
4.52
6.4
4.2
327.71
2733.77
e6/l
—
7
22
74
466
1.84
4.36
3.1
2.1
—
—
—
0
0
13
29
4.67
4.31
1.5
1.4
—
—
—
0
0
231
2072
3.01
4.23
25.2
11.4
16.98
20.39
mg/l
1.18
204
1578
16
52
3.22
4.16
1.1
1.2
3.09
29.19
e6/l
1.05
11
42
16
52
3.22
4.16
1.1
1.0
1.40
2.41
e6/l
—
10
39
91
617
1.76
4.16
3.3
3.0
34.83
39.27
ng/l
0.07
50
338
129
965
1.71
4.13
11.3
5.5
10.96
11.70
umol/l
0.17
124
905
7
7
10.25
4.03
1.9
4.1
187.71
97.14
%
—
7
7
52
302
1.92
3.90
3.5
2.6
2.44
2.44
mmol/l
0.04
46
259
14
44
3.31
3.84
1.2
1.1
—
—
—
0
0
14
39
3.74
3.77
1.8
1.4
—
—
—
0
0
14
39
3.74
3.77
1.7
1.2
1.67
1.18
u/ml
—
6
11
14
39
3.74
3.77
1.8
1.4
—
—
—
0
0
13
34
3.98
3.75
1.2
1.1
0.14
0.63
u/ml
—
8
10
14
46
3.17
3.59
1.4
1.2
—
—
—
0
0
87
607
1.67
3.48
3.4
2.9
2.35
2.35
mmol/l
0.04
77
550
10
22
4.69
3.47
1.3
1.1
—
—
—
0
0
10
22
4.69
3.47
1.3
1.1
—
—
—
0
0
10
22
4.69
3.47
1.3
1.1
—
—
—
0
0
190
1622
1.76
3.39
5.2
3.7
—
—
—
0
0
19
77
2.59
3.39
1.1
1.4
—
—
—
0
0
21
90
2.46
3.35
1.8
1.7
—
—
—
0
0
189
1620
1.73
3.22
5.5
4.2
14.45
14.47
pmol/l
0.03
178
1500
8
16
5.13
3.07
1.3
1.0
—
—
—
0
0
9
22
4.21
2.91
1.3
1.1
—
—
—
0
0
9
22
4.21
2.91
1.3
1.1
—
—
—
0
0
37
212
1.88
2.87
7.3
6.4
1.04
1.06
mmol/l
0.11
37
198
57
372
1.69
2.87
3.2
2.8
418.84
742.64
ng/l
2.39
50
298
10
28
3.68
2.81
2.8
2.1
—
—
—
0
0
14
54
2.69
2.75
1.2
1.4
350.43
311.88
ug/g
—
7
30
124
983
1.53
2.73
3.4
2.5
—
—
—
0
0
9
24
3.85
2.70
1.1
1.1
—
—
—
0
0
21
100
2.20
2.68
1.7
1.6
—
—
—
0
0
78
563
1.57
2.61
1.5
1.3
1.47
1.74
u/ml
0.11
11
153
57
383
1.64
2.56
1.4
1.3
13.51
27.55
iu/ml
1.62
14
130
7
16
4.47
2.49
1.3
1.1
—
—
—
0
0
43
272
1.70
2.42
1.7
1.7
1268.03
1191.03
nmol/l
0.18
34
210
9
27
3.42
2.42
1.1
1.1
—
—
—
0
0
9
28
3.30
2.33
1.1
1.1
—
—
—
0
0
21
107
2.05
2.28
7.8
8.2
25.33
24.87
mmol/l
0.25
21
107
9
29
3.18
2.25
1.1
1.1
—
—
—
0
0
208
1887
1.68
2.22
19.4
9.9
92.19
90.08
ml/min/173m2
0.71
190
1523
6
14
4.36
2.16
2.2
1.1
—
—
—
0
0
230
2153
2.12
2.15
16.4
8.9
27.36
24.81
u/l
1.57
225
2081
208
1897
1.64
2.05
6.5
4.9
1.68
1.80
mu/l
1.08
202
1765
163
1414
1.46
2.03
4.8
2.9
40.75
39.41
u/l
0.11
157
1346
10
39
2.63
1.96
1.1
1.1
—
—
—
0
0
5
11
4.61
1.95
1.4
1.0
—
—
%
—
0
0
32
199
1.70
1.92
1.2
1.3
182.00
141.17
iu/ml
0.20
17
79
14
65
2.22
1.92
1.3
1.4
—
—
—
0
0
65
482
1.47
1.86
1.7
1.7
1.35
1.38
mmol/l
0.11
56
408
53
377
1.52
1.85
1.4
1.3
2.88
9.81
u/ml
1.82
13
157
12
53
2.33
1.84
2.8
1.7
—
—
—
0
0
9
36
2.56
1.76
2.0
1.5
—
—
—
0
0
5
13
3.90
1.72
1.0
1.1
—
—
—
0
0
28
174
1.69
1.70
1.8
2.4
31129.99
3624.70
u/l
—
8
80
6
19
3.21
1.67
1.3
1.1
—
—
—
0
0
7
25
2.85
1.66
1.4
1.9
—
—
—
0
0
7
25
2.85
1.66
1.4
1.9
—
—
—
0
0
5
14
3.62
1.62
2.6
3.6
25.80
23.64
umol/l
—
5
14
10
43
2.38
1.61
1.5
1.8
—
—
—
0
0
12
57
2.16
1.58
1.6
1.3
—
—
—
0
0
240
2322
2.65
1.54
33.4
17.2
133.33
134.59
g/l
0.75
240
2294
240
2321
2.67
1.54
33.7
17.1
39.78
40.13
%
0.46
229
2213
19
110
1.79
1.47
1.5
1.3
179.12
308.39
miu/ml
—
10
54
9
38
2.42
1.47
2.4
1.8
—
—
—
0
0
9
38
2.42
1.47
2.4
1.8
—
—
—
0
0
5
16
3.17
1.44
1.2
1.3
—
—
—
0
0
6
22
2.77
1.44
1.5
1.3
—
—
—
0
0
9
40
2.30
1.41
1.1
1.4
—
—
—
0
0
6
23
2.65
1.37
1.2
1.0
—
—
—
0
0
10
47
2.18
1.35
1.2
1.2
—
1.16
—
0
5
20
122
1.70
1.32
2.0
1.6
—
—
—
0
0
11
55
2.05
1.29
2.6
1.7
—
—
—
0
0
6
25
2.43
1.25
3.2
1.9
—
—
—
0
0
8
37
2.20
1.22
2.5
1.4
—
—
—
0
0
8
37
2.20
1.22
6.8
5.7
22.89
24.55
mmol/l
—
8
37
8
38
2.14
1.19
9.6
3.5
59.13
57.45
%
—
8
38
10
50
2.04
1.18
7.7
10.2
9.10
8.33
kpa
—
10
50
8
39
2.09
1.16
2.9
1.7
—
—
—
0
0
7
30
2.37
1.13
2.1
1.7
—
—
—
0
0
8
40
2.03
1.13
2.4
1.8
—
—
—
0
0
7
31
2.29
1.11
1.0
1.1
—
10.88
—
0
8
5
21
2.41
1.09
1.0
1.3
—
—
—
0
0
5
21
2.41
1.09
1.2
1.6
—
—
—
0
0
5
21
2.41
1.09
3.6
2.0
—
—
—
0
0
12
67
1.83
1.06
3.3
2.5
0.84
0.67
%
1.16
12
67
5
22
2.30
1.04
1.6
1.2
—
—
—
0
0
12
68
1.80
1.02
1.3
1.1
—
—
—
0
0
185
1720
1.31
1.02
5.1
4.8
38.52
38.41
mmol/mol
0.05
176
1617
114
1000
1.26
1.02
3.6
3.5
0.00
0.00
estimate
0.50
18
218
9
48
1.91
1.01
1.3
1.3
—
103.92
—
0
12
9
48
1.91
1.01
3.1
1.9
—
—
—
0
0
11
61
1.84
1.00
1.3
1.5
—
—
—
0
0
9
51
1.79
0.95
1.2
1.4
26.56
35.02
nmol/l
—
9
51
25
176
1.47
0.95
3.0
3.1
—
—
—
0
0
12
70
1.75
0.94
3.3
2.5
1.35
1.19
%
0.25
12
70
197
1858
1.31
0.89
4.2
3.8
5.78
5.71
mmol/l
0.29
187
1728
6
112
0.52
0.85
1.7
1.7
—
—
—
0
0
6
31
1.96
0.85
1.2
1.2
—
—
—
0
0
113
1012
1.22
0.78
3.8
3.5
0.00
0.00
estimate
-0.00
16
203
5
25
2.02
0.73
2.2
1.7
—
—
—
0
0
19
136
1.43
0.69
2.1
3.0
76.00
78.76
ml/min/173m2
—
9
54
5
27
1.87
0.69
1.2
1.1
—
—
—
0
0
12
78
1.57
0.67
1.3
1.2
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
8
50
1.62
0.62
1.6
1.2
—
—
—
0
0
110
1000
1.18
0.62
5.6
4.8
0.00
0.00
estimate
0.50
17
212
11
73
1.53
0.57
1.2
1.9
—
—
—
0
0
6
37
1.64
0.56
7.5
4.0
16.32
23.97
mg/l
—
6
31
6
37
1.64
0.56
7.3
4.0
93.38
40.18
mg/l
—
6
31
10
66
1.54
0.53
3.5
1.9
—
—
—
0
0
9
63
1.44
0.53
2.6
1.9
—
—
—
0
0
11
75
1.49
0.51
1.5
3.2
4.32
6.12
umol/l
—
6
55
10
67
1.51
0.50
5.0
5.3
56.94
46.81
%
—
10
67
7
110
0.63
0.49
3.0
1.5
—
—
—
0
0
46
529
0.84
0.46
4.0
3.8
0.00
0.00
estimate
0.50
16
208
49
427
1.18
0.45
3.3
3.9
30.21
50.09
mg/mmol
0.18
31
268
5
32
1.57
0.42
3.2
2.1
13.40
13.22
%
—
5
32
13
170
0.75
0.39
1.4
1.5
—
—
—
0
0
15
191
0.77
0.38
10.5
6.2
—
—
—
0
0
6
45
1.34
0.34
1.2
1.1
—
—
—
0
0
73
787
0.90
0.30
3.9
3.4
—
—
—
0
0
10
130
0.76
0.30
1.3
1.6
—
—
—
0
0
11
140
0.78
0.29
1.5
2.5
27.04
38.72
u/ml
0.44
11
134
33
293
1.15
0.25
2.1
1.9
—
—
—
0
0
26
227
1.16
0.25
1.8
1.8
—
—
—
0
0
23
264
0.86
0.24
1.3
1.5
—
—
—
0
0
56
518
1.11
0.23
1.6
1.5
—
—
—
0
0
18
154
1.18
0.22
1.2
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
130.87
—
0
14
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
9
78
1.16
0.15
1.3
1.2
—
—
—
0
0
17
150
1.14
0.15
1.1
1.0
—
—
—
0
0
21
232
0.90
0.14
2.7
4.0
23.36
22.54
%
—
9
107
8
99
0.80
0.14
1.4
2.2
—
—
—
0
0
199
1964
1.07
0.12
4.5
4.1
2.78
2.83
mmol/l
0.30
190
1843
16
145
1.11
0.09
1.2
1.4
—
—
—
0
0
16
145
1.11
0.09
1.2
1.4
—
—
—
0
0
16
145
1.11
0.09
1.2
1.4
—
—
—
0
0
50
479
1.06
0.09
3.0
2.2
—
—
—
0
0
16
146
1.10
0.08
1.2
1.4
—
—
—
0
0
12
108
1.12
0.07
1.3
1.4
—
—
—
0
0
190
1882
1.04
0.07
3.8
3.4
1.32
1.23
mmol/l
0.90
182
1756
193
1944
0.97
0.05
4.3
3.8
4.63
4.73
mmol/l
0.78
186
1833
44
432
1.02
0.01
3.1
2.0
—
—
—
0
0
193
1937
0.98
0.01
4.2
3.8
1.45
1.50
mmol/l
0.81
183
1818
23
229
1.00
0.00
1.9
1.6
—
—
—
0
0
15
146
1.03
0.00
2.1
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
61
0.98
-0.00
1.0
1.1
1.79
3.16
ug/l
—
6
53
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
12.15
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST – Other and unspecified vaccines and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).